News and Press - Avicanna

Avicanna Reports Q1 2022 Financial Statement and Management Change

Avicanna Announces Closing of Strategic Private Placement

Avicanna Expands RHO PhytoTM Formulary with the Introduction of Cannabigerol (CBG) Products into the Canadian Market

Avicanna Enters into Exclusive License and Supply Agreement with Major South American Pharmaceutical Company

Avicanna Expands its Derma-Cosmetics Brand Pura H&W™ into the European Union through a Partnership with Bio-Gate AG

Avicanna Announces Filing of Annual Financial Statements for Year Ended December 31, 2021

« Prev 1 2 3 4 5 6 7 Next »